New York State Common Retirement Fund Bolt Biotherapeutics, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.41 - $2.91 $14,382 - $29,682	-10,200 Reduced 98.19%	188 $0
Q4 2021 Feb 02, 2022	BUY	$4.19 - $13.97 $24,561 - $81,892	5,862 Added 129.52%	10,388 $51,000
Q3 2021 Nov 02, 2021	SELL	$11.15 - $18.6 $77,849 - $129,865	-6,982 Reduced 60.67%	4,526 $57,000
Q2 2021 Aug 02, 2021	BUY	$15.4 - $31.46 $50,943 - $104,069	3,308 Added 40.34%	11,508 $178,000
Q1 2021 May 11, 2021	BUY	$25.86 - $39.93 $212,052 - $327,426	8,200 New	8,200 $270,000

24.3M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $28.2M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.